Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) closed at $23.30 down -2.43% from its previous closing price of $23.88. In other words, the price has decreased by -$2.43 from its previous closing price. On the day, 0.58 million shares were traded. AMPH stock price reached its highest trading level at $23.97 during the session, while it also had its lowest trading level at $23.265.
Ratios:
For a deeper understanding of Amphastar Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.59 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.31. For the most recent quarter (mrq), Quick Ratio is recorded 2.02 and its Current Ratio is at 2.95. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.86.
On February 04, 2025, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $66 to $36.
On November 22, 2024, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $55.Wells Fargo initiated its Equal Weight rating on November 22, 2024, with a $55 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 01 ’25 when Petersen Floyd F. sold 500 shares for $24.08 per share. The transaction valued at 12,041 led to the insider holds 73,409 shares of the business.
Petersen Floyd F. bought 500 shares of AMPH for $12,095 on May 01 ’25. On Apr 01 ’25, another insider, Petersen Floyd F., who serves as the Director of the company, sold 500 shares for $28.38 each. As a result, the insider received 14,190 and left with 73,909 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMPH now has a Market Capitalization of 1098340992 and an Enterprise Value of 1513990656. As of this moment, Amphastar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 8.46, and their Forward P/E ratio for the next fiscal year is 6.64. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.50 while its Price-to-Book (P/B) ratio in mrq is 1.48. Its current Enterprise Value per Revenue stands at 2.072 whereas that against EBITDA is 6.098.
Stock Price History:
The Beta on a monthly basis for AMPH is 0.74, which has changed by -0.45484322 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, AMPH has reached a high of $53.96, while it has fallen to a 52-week low of $22.64. The 50-Day Moving Average of the stock is -9.75%, while the 200-Day Moving Average is calculated to be -39.21%.
Shares Statistics:
For the past three months, AMPH has traded an average of 652.96K shares per day and 661810 over the past ten days. A total of 47.67M shares are outstanding, with a floating share count of 34.81M. Insiders hold about 26.15% of the company’s shares, while institutions hold 69.91% stake in the company. Shares short for AMPH as of 1745971200 were 3206270 with a Short Ratio of 4.91, compared to 1743379200 on 3422379. Therefore, it implies a Short% of Shares Outstanding of 3206270 and a Short% of Float of 13.28.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
